# clm_A38CF4ED791C

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: research_and_development  
value: 3,486,700,000 United States dollar  
valid_from: 2007-12-31  
valid_to: 2008-12-31  
published: 2010-02-22  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_AFD07F967D55  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company research and development: 3,486,700,000 United States dollar", as of 2007-12-31 (until 2008-12-31). Claim clm_A38CF4ED791C, https://asof.is/claim/clm_A38CF4ED791C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000095012310014958/0000950123-10-014958-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-K FY2009, filed 2010-02-22  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000095012310014958/0000950123-10-014958-index.htm (primary, SEC EDGAR 10-K FY2009, published 2010-02-22)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.